A phase I study of hyper-CVAD in combination with Venetoclax in pediatric patients with relapsed or refractory acute leukemias that are of the lymphoid lineage including bi-phenotypic or undifferentiated leukemias

Disease:

Refractory Acute Leukemia, Relapsed Acute Leukemia, Undifferentiated Leukemia, Bi-Phenotypic Leukemia

Study phase:

Phase I

Physician name:

David McCall

Department:

Pediatrics

For general questions about clinical trials:

1-844-491-2084